Search Results

Drugs to Watch: Oncology and Cell/Gene Therapies.

Subjects: GENE therapy; PATIENT safety; RARE diseasesUNITED States. Food & Drug Administration

• Source: Formulary Watch. Sep2024, p6-9. 4p.

Record details

Promising Results Reported in Early-Phase Gene Therapy Trials for Two Types of Inherited Blindness.

• Authors : Sapatkin, Don

Subjects: GENETICS of blindness; GENE therapy; PATIENT safetyUNITED States. Food & Drug Administration

• Source: Formulary Watch. 9/26/2024, p3-3. 1p.

Record details

Taking Full Advantage of Service Providers.

• Authors : Husni, Daria

Subjects: *CONTRACTING out; *NEW product development; *ORGANIZATIONAL effectiveness

• Source: Pharmaceutical Technology. Apr2024, Vol. 48 Issue 4, p40-41. 2p.

Record details

Agricola

Record details

3 Things You Should Know About Developments in Treating XLRP.

• Authors : Pennesi, Mark¹; Devisetty, Laxmi V.²; Fischer, M. Dominik³

Subjects: *GENE therapy; *CONTINUING education units; *RISK assessment

• Source: Ophthalmology Times. Aug2024, Vol. 49 Issue 8, p34-36. 3p.

Record details

A new age of precision gene therapy.

• Authors : Schambach, Axel (AUTHOR); Buchholz, Christian J (AUTHOR); Torres-Ruiz, Raul (AUTHOR)

Subjects: GENE therapy; GENOME editing; CLINICAL trials

• Source: Lancet. Feb2024, Vol. 403 Issue 10426, p568-582. 15p.

Record details

Gene therapy tourists.

• Authors : Hilsum, Lindsey¹

Subjects: CANCER treatment; GENE therapy; CLINICAL trialsUNITED States; UNITED Kingdom; CHINA

• Source: New Statesman. 2/5/2007, Vol. 136 Issue 4830, p22-23. 2p.

Record details

Benefits of Gene Therapy for Cerebral ALD Persist at 6 Years, but With Malignancy Risk.

• Authors : Shaw, Gina (AUTHOR)

Subjects: *GENE therapy; *ADRENOLEUKODYSTROPHY; *RISK assessment

• Source: Neurology Today. 11/21/2024, Vol. 24 Issue 22, p21-22. 2p.

Record details

Agricola

Record details

BridgeBio slashes gene therapy budget after early-phase data fall short of 'transformational' target.

• Authors : Taylor, Nick Paul (AUTHOR)

Subjects: *CHIEF executive officers; GENE therapy; CELLULAR therapy

• Source: FierceBiotech. 9/11/2024, pN.PAG-N.PAG. 1p.

Record details